Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tactile Systems Technology, Inc.    TCMD

TACTILE SYSTEMS TECHNOLOGY, INC.

(TCMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/06/2020 07/07/2020 07/08/2020 07/09/2020 07/10/2020 Date
39.99(c) 38.04(c) 37.35(c) 36.73(c) 36.02(c) Last
185 952 210 298 284 318 195 833 106 385 Volume
-2.15% -4.88% -1.81% -1.66% -1.93% Change
More quotes
Financials (USD)
Sales 2020 195 M - -
Net income 2020 1,65 M - -
Net Debt 2020 - - -
P/E ratio 2020 8 396x
Yield 2020 -
Sales 2021 247 M - -
Net income 2021 12,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 64,2x
Yield 2021 -
Capitalization 693 M 693 M -
Capi. / Sales 2020 3,56x
Capi. / Sales 2021 2,81x
Nbr of Employees 629
Free-Float 95,8%
More Financials
Company
Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch... 
More about the company
Surperformance© ratings of Tactile Systems Technology
Trading Rating : Investor Rating :
More Ratings
Latest news on TACTILE SYSTEMS TECHNOLOGY
06/24Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tactile Syst..
PR
06/22Tactile Medical to Release Second Quarter of Fiscal Year 2020 Financial Resul..
GL
06/19THE LAW OFFICES OF FRANK R. CRUZ : Continues Its Investigation on Behalf of Tact..
BU
06/15TCMD SHAREHOLDER INVESTIGATION : The Law Firm of Barbuto & Johansson, P.A. Inves..
AQ
06/12GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Continues Invest..
BU
06/11Law Offices of Howard G. Smith Continues Investigation of Tactile Systems Tec..
BU
06/11THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation on Behalf of Tactile ..
BU
06/10GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Announces Invest..
BU
06/10Law Offices of Howard G. Smith Announces Investigation of Tactile Systems Tec..
BU
06/10INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claim..
BU
06/10TCMD INVESTOR ALERT : Bronstein, Gewirtz & Grossman, LLC Announces Investigation..
PR
06/09HAGENS BERMAN, NATIONAL TRIAL ATTORN : Firm Investigating Possible Securities Fr..
PR
06/09INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
06/09TCMD Kirby McInerney LLP Announces Investigation of Shareholder Claims Agains..
BU
06/09ROSEN, A LONGSTANDING AND TRUSTED LAW FIRM, Announces Investigation of Securi..
BU
More news
News in other languages on TACTILE SYSTEMS TECHNOLOGY
06/24Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tactile Syst..
06/22Tactile Medical to Release Second Quarter of Fiscal Year 2020 Financial Resul..
06/19THE LAW OFFICES OF FRANK R. CRUZ : Continues Its Investigation on Behalf of Tact..
06/15TCMD SHAREHOLDER INVESTIGATION : The Law Firm of Barbuto & Johansson, P.A. Inves..
06/12GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Continues Invest..
More news
Chart TACTILE SYSTEMS TECHNOLOGY
Duration : Period :
Tactile Systems Technology Technical Analysis Chart | TCMD | US87357P1003 | MarketScreener
Technical analysis trends TACTILE SYSTEMS TECHNOLOGY
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 65,20 $
Last Close Price 36,02 $
Spread / Highest target 94,3%
Spread / Average Target 81,0%
Spread / Lowest Target 69,4%
EPS Revisions
Managers
NameTitle
Daniel L. Reuvers President & Chief Executive Officer
Peter H. Soderberg Chairman
Robert J. Folkes Chief Operating Officer
Brent A. Moen Chief Financial Officer
Darren J. Wennen Vice President-Marketing & Clinical Affairs
Sector and Competitors